| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 80.86▲ | 80.83▲ | 80.95▲ | 79.78▲ | 82.39▼ |
| MA10 | 80.87▲ | 80.92▲ | 80.64▲ | 78.23▲ | 82.66▼ |
| MA20 | 80.89▲ | 80.55▲ | 80.35▲ | 82.08▼ | 80.08▲ |
| MA50 | 80.93▲ | 80.11▲ | 78.98▲ | 83.23▼ | 78.12▲ |
| MA100 | 80.74▲ | 78.78▲ | 80.36▲ | 79.45▲ | 94.54▼ |
| MA200 | 80.29▲ | 81.00▼ | 82.83▼ | 79.50▲ | 87.93▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | -0.009▼ | 0.023▲ | -0.016▼ | -0.106▼ |
| RSI | 55.256▲ | 59.187▲ | 62.415▲ | 48.082▼ | 49.474▼ |
| STOCH | 52.338 | 38.725 | 63.606 | 54.744 | 48.230 |
| WILL %R | -15.873▲ | -45.854 | -31.126 | -59.486 | -59.486 |
| CCI | 80.000 | -12.191 | 56.620 | 17.383 | -124.736▼ |
|
Saturday, August 16, 2025 02:30 AM
DexCom, a diabetes-focused medical device maker, delivered strong second-quarter results. The company's revenue increased by 15% year over year to $1.16 billion, while its EPS rose 29% year over year ...
|
|
Thursday, August 14, 2025 02:08 AM
Over the last six months, DexCom’s shares have sunk to $80.25, producing a disappointing 9.9% loss - a stark contrast to the S&P 500’s 5.8% gain. This may have investors wondering how to approach the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 80.29 | 82.04 | 80.29 | 80.95 | 2,232,900 |
| 14/08/25 | 79.74 | 80.205 | 78.87 | 79.96 | 2,234,124 |
| 13/08/25 | 80.67 | 81.56 | 79.87 | 79.96 | 4,278,200 |
| 12/08/25 | 78.475 | 80.36 | 78.145 | 80.17 | 3,424,873 |
| 11/08/25 | 78.74 | 79.22 | 77.60 | 77.85 | 4,224,200 |
| 08/08/25 | 76.27 | 79.05 | 76.27 | 78.86 | 3,865,800 |
| 07/08/25 | 77.12 | 77.95 | 75.59 | 76.40 | 3,083,500 |
| 06/08/25 | 75.48 | 77.95 | 74.80 | 76.40 | 4,828,000 |
| 05/08/25 | 76.30 | 76.53 | 74.88 | 75.46 | 5,630,600 |
| 04/08/25 | 79.90 | 80.22 | 75.94 | 76.25 | 6,537,000 |
|
|
||||
|
|
||||
|
|